Literature DB >> 3403573

Ischemic necrosis of the femoral head. Treatment by core decompression.

C N Hopson1, S W Siverhus.   

Abstract

Since 1977, we have performed twenty-one core decompressions in seventeen patients who had stage-I or II ischemic necrosis of the femoral head. The diagnosis was confirmed histologically in all but one patient. After a mean length of follow-up of thirty-nine months, healing was evident in eight hips (40 per cent) but not in the other twelve. All twelve hips required additional surgical treatment; the average length of time before the additional treatment was required was 9.2 months. The results of two intraoperative diagnostic tests (intramedullary pressure and saline stress tests) did not correlate with the results of biopsy. A perioperative fracture through the site of the decompression occurred in one of the twenty-one hips. Given the relatively poor long-term results and the considerable morbidity that was associated with core decompression, this treatment cannot be recommended.

Entities:  

Mesh:

Year:  1988        PMID: 3403573

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  10 in total

1.  A current review of core decompression in the treatment of osteonecrosis of the femoral head.

Authors:  Todd P Pierce; Julio J Jauregui; Randa K Elmallah; Carlos J Lavernia; Michael A Mont; James Nace
Journal:  Curr Rev Musculoskelet Med       Date:  2015-09

2.  The prevalence and natural history of early osteonecrosis (ON) of the femoral head.

Authors:  B D Mulliken; D L Renfrew; R A Brand; C G Whitten
Journal:  Iowa Orthop J       Date:  1994

3.  Epidermal growth factor (EGF) promotes bone healing in surgically induced osteonecrosis of the femoral head (ONFH).

Authors:  Ozgur Basal; Tolga Atay; İbrahim Metin Ciris; Yakup Barbaros Baykal
Journal:  Bosn J Basic Med Sci       Date:  2018-11-07       Impact factor: 3.363

4.  Outcome of painful bone marrow edema of the femoral head following treatment with parenteral iloprost.

Authors:  Roland Meizer; Dominik Meraner; Elisabeth Meizer; Christian Radda; Franz Landsiedl; Nicolas Aigner
Journal:  Indian J Orthop       Date:  2009-01       Impact factor: 1.251

5.  Revascularization of femoral head ischemic necrosis with vascularized bone graft: a CT scan experimental study.

Authors:  J González del Pino; K Knapp; F Gómez Castresana; M Benito
Journal:  Skeletal Radiol       Date:  1990       Impact factor: 2.199

6.  An exploratory clinical trial for idiopathic osteonecrosis of femoral head by cultured autologous multipotent mesenchymal stromal cells augmented with vascularized bone grafts.

Authors:  Tomoki Aoyama; Koji Goto; Ryosuke Kakinoki; Ryosuke Ikeguchi; Michiko Ueda; Yasunari Kasai; Taira Maekawa; Harue Tada; Satoshi Teramukai; Takashi Nakamura; Junya Toguchida
Journal:  Tissue Eng Part B Rev       Date:  2014-04-09       Impact factor: 6.389

Review 7.  Do modern techniques improve core decompression outcomes for hip osteonecrosis?

Authors:  David R Marker; Thorsten M Seyler; Slif D Ulrich; Siddharth Srivastava; Michael A Mont
Journal:  Clin Orthop Relat Res       Date:  2008-04-08       Impact factor: 4.176

8.  Dimethyloxaloylglycine increases bone repair capacity of adipose-derived stem cells in the treatment of osteonecrosis of the femoral head.

Authors:  Zhen-Hong Zhu; Wen-Qi Song; Chang-Qing Zhang; Ji-Min Yin
Journal:  Exp Ther Med       Date:  2016-09-13       Impact factor: 2.447

9.  Peripheral Blood-Derived Stem Cells for the Treatment of Cartilage Injuries: A Systematic Review.

Authors:  Yanlin Zhu; Weili Fu
Journal:  Front Bioeng Biotechnol       Date:  2022-07-22

10.  Management of osteonecrosis of the femoral head: A novel technique.

Authors:  Ahmed M Samy
Journal:  Indian J Orthop       Date:  2016 Jul-Aug       Impact factor: 1.251

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.